Barclays, Glazer Capital and BlackRock disclose stakes in Advanced Medical Solutions
Barclays, Glazer Capital and BlackRock disclosed holdings of about 2.7% to 3.9% in Advanced Medical Solutions Group under UK takeover rules, per RNS filings.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Barclays, Glazer Capital and BlackRock each filed mandatory Form 8.3 disclosures through RNS on their positions in Advanced Medical Solutions Group plc. Reuters reported the filings, which are required under the UK Takeover Code once a holder's stake reaches at least 1%.
As of October 27, Barclays held 7,598,251 shares, or 3.44%, and also had short positions in 952,546 shares, or 0.43%. Glazer Capital reported 6,364,026 shares, or 2.88%, and bought 250,000 shares at 2.82 pounds each that day. BlackRock held 6,054,054 shares, or 2.73%, after a small purchase of 321 shares at 2.8250 pounds.
why it matters
The filings contain no new financial results from the company, but they show that large investors are actively trading the stock. For the market, this signals attention to the company during a takeover process rather than a direct driver of its share price.
tags
instruments
sources
- REG - Barclays PLC Adv Medical Solutns. - Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC — Reuters, 28 October 2026 at 14:06 UTC
- REG - Glazer Capital, LLC Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc — Reuters, 28 October 2026 at 15:25 UTC
- REG - BlackRock Group Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc — Reuters, 28 October 2026 at 15:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗